Nothing Special   »   [go: up one dir, main page]

Paterson, 1985 - Google Patents

Drug levels found in cases of fatal self-poisoning

Paterson, 1985

Document ID
14296074178611607675
Author
Paterson S
Publication year
Publication venue
Forensic science international

External Links

Snippet

A list of drug levels found in cases of fatal self-poisoning is presented here. These are all cases where only one drug was found and the cause of death in each case was attributed to an overdose of that particular drug. For each case a full drug screen was carried out. In …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor

Similar Documents

Publication Publication Date Title
Gill et al. Brain levels of Δ1-tetrahydrocannabinol and its metabolites in mice—correlation with behaviour, and the effect of the metabolic inhibitors SKF 525A and piperonyl butoxide
Cimbura et al. Incidence and toxicological aspects of drugs detected in 484 fatally injured drivers and pedestrians in Ontario
Kogan et al. Quantitative determination of benzoylecgonine and cocaine in human biofluids by gas-liquid chromatography
Seidl et al. Ethyl glucuronide—a biological marker for recent alcohol consumption
Garside et al. Identification of cocaine analytes in fingernail and toenail specimens
Jones et al. Concentration distributions of the drugs most frequently identified in post-mortem femoral blood representing all causes of death
DiGregorio et al. Diazepam concentrations in parotid saliva, mixed saliva, and plasma
Paterson Drug levels found in cases of fatal self-poisoning
Kłys et al. Usefulness of multi-parameter opiates–amphetamines–cocainics analysis in hair of drug users for the evaluation of an abuse profile by means of LC–APCI-MS-MS
Jones et al. Driving under the influence of opiates: concentration relationships between morphine, codeine, 6-acetyl morphine, and ethyl morphine in blood
De Giovanni et al. A systematic review of solid-phase microextraction applications in the forensic context
Jones Postmortem toxicology
Riggs et al. Determination of metoclopramide and two of its metabolites using a sensitive and selective gas chromatographic—mass spectrometric assay
Nakamura Toxicologic assessments in acute heroin fatalities
Nowatzke et al. Distinction among eight opiate drugs in urine by gas chromatography-mass spectrometry
Peat et al. Toxicological investigations of cases of death involving codeine and dihydrocodeine
Winborn et al. Quantitative analysis of desomorphine in blood and urine using solid phase extraction and gas chromatography-mass spectrometry
Kangas Determination of nitrazepam and its main metabolites in urine by gas-liquid chromatography: Use of electron capture and nitrogen-selective detectors
Schroeder et al. Evaluation of Syva EMIT® toxicological serum tricyclic antidepressant assay
Watson et al. Assessment of cerebrospinal fluid levels of dopamine metabolites by gas chromatography
Alha et al. Prevalence of drugs among drivers arrested for drinking and driving in Finland
Hall et al. Ratios for very-long-chain fatty acids in plasma of subjects with peroxisomal disorders, as determined by HPLC and validated by gas chromatography-mass spectrometry.
Gjerde et al. A case of high opiate tolerance: implications for drug analyses and interpretations
Balikova et al. High-performance liquid chromatographic confirmation of cocaine and benzoylecgonine in biological samples using photodiode-array detection after toxicological screening
Kwong et al. Analysis of digoxin at therapeutic concentrations using high-performance liquid chromatography with post-column derivatization